Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. [electronic resource]
Producer: 20100217Description: 303-14 p. digitalISSN:- 1365-2249
- Anaphylatoxins -- immunology
- Animals
- Antibodies, Monoclonal -- immunology
- Antigens, CD -- immunology
- Autoimmune Diseases -- drug therapy
- Complement Activation -- drug effects
- Complement C5 -- antagonists & inhibitors
- Complement Membrane Attack Complex -- immunology
- Disease Models, Animal
- Inflammation -- drug therapy
- Interferon-gamma -- immunology
- Mice
- Nitric Oxide -- immunology
- Rats
- Retinitis -- drug therapy
- Severity of Illness Index
- Signal Transduction -- drug effects
- Uveitis -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.